Epithalon (Epitalon) · Research brief

How to Mix Epithalon — Reconstitution Protocol Explained

Q: How much bacteriostatic water should I use to mix epithalon?

Use 2–3ml of bacteriostatic water per 10mg of lyophilised epithalon to achieve a working concentration of 3.3–5mg/ml, or use 10ml for a more dilute 1mg/ml solution. The 1mg/ml dilution is standard in published epithalon research protocols because it reduces aggregation risk and allows precise dosing with standard insulin syringes. Higher concentrations above 5mg/ml increase precipitation risk as the peptide approaches its solubility ceiling in aqueous solution.

Q: Can I use sterile water instead of bacteriostatic water to mix epithalon?

Sterile water lacks the benzyl alcohol preservative present in bacteriostatic water, which means the reconstituted solution cannot be stored as a multi-dose vial — it must be used immediately or within 24 hours to prevent bacterial contamination. Bacteriostatic water maintains sterility for 28 days in a sealed vial, making it the preferred diluent for peptides that require refrigerated storage between doses. If you’re conducting a single-injection protocol, sterile water is acceptable, but for any multi-dose application, bacteriostatic water is required.

Q: What happens if I shake the epithalon vial after adding water?

Vigorous shaking introduces mechanical shear stress that fragments the Ala-Glu-Asp-Gly peptide chain, reducing bioactivity by 10–15% on first contact. Shaking also creates air bubbles that increase oxidation — dissolved oxygen attacks the peptide backbone at the Glu and Asp residues, accelerating degradation. Instead of shaking, gently roll the vial between your palms in a circular motion to encourage passive dissolution without turbulence. Most lyophilised epithalon fully dissolves within 3–5 minutes using this method.

Q: How long does reconstituted epithalon remain stable in the refrigerator?

Reconstituted epithalon stored at 2–8°C in a sealed vial maintains structural integrity for 28 days — after that point, oxidation and peptide bond hydrolysis reduce potency below therapeutic thresholds regardless of visual appearance. The 28-day window assumes strict temperature control without excursions above 8°C. If the vial experiences room-temperature exposure for more than 6 cumulative hours across the storage period, reduce the usable window to 14 days. Never freeze reconstituted epithalon — ice crystal formation irreversibly denatures the peptide.

Q: What is the correct needle size for reconstituting epithalon?

Use an 18-gauge needle to draw bacteriostatic water from the stock vial (faster draw with less vacuum created), then switch to a 25-gauge or 27-gauge needle for the actual injection into the epithalon vial. Smaller needles create smaller puncture wounds in the rubber stopper, which reduces contamination risk on subsequent draws from multi-dose vials. Never reuse needles — dulled tips tear the stopper instead of puncturing cleanly, creating irregular openings that allow bacterial infiltration.

Q: Why does my reconstituted epithalon look cloudy after mixing?

Cloudiness indicates either peptide aggregation or bacterial contamination — both render the solution unusable for research. Aggregation occurs when epithalon molecules clump due to pH drift (bacteriostatic water outside the 5.5–7.0 range), temperature stress (reconstitution at room temperature instead of refrigerated), or mechanical shear from vigorous shaking. Bacterial contamination presents as cloudiness with a faint odour or visible sediment. Properly reconstituted epithalon should be crystal-clear with no particulates. If cloudiness appears, discard the vial and verify your bacteriostatic water source and reconstitution technique.

Q: Can I mix epithalon with other peptides in the same vial?

No — mixing multiple peptides in a single vial creates unpredictable interactions that can alter pH, induce cross-aggregation, or accelerate degradation of both compounds. Each peptide has distinct solubility profiles, optimal pH ranges, and stability windows that are incompatible with co-formulation outside pharmaceutical-grade manufacturing. If your research protocol requires multiple peptides, reconstitute each in a separate sterile vial and administer them as individual injections. The only exception is pre-formulated peptide blends from suppliers who have verified stability data for that specific combination.

Q: What is the difference between research-grade and pharmaceutical-grade epithalon?

Research-grade epithalon is synthesised for in-vitro and in-vivo laboratory studies under GMP conditions with purity verified by HPLC and mass spectrometry (typically >98%), but it is not approved for human therapeutic use by regulatory bodies like the FDA. Pharmaceutical-grade peptides undergo additional cGMP manufacturing with batch-by-batch sterility testing, endotoxin screening, and formal regulatory approval — a process epithalon has not completed in most jurisdictions. Research-grade material from verified suppliers like Real Peptides delivers the same amino acid sequence and purity level, but it is labelled and sold exclusively for laboratory research, not clinical administration.

Real Peptides Research TeamEditorial

Updated July 6, 202611 min read

59 WORDS

Short answer

Key takeaways

Epithalon must be reconstituted with bacteriostatic water at a 45-degree angle against the vial wall to prevent mechanical shear stress that denatures up to 15% of the peptide on contact.
The reconstituted solution remains stable for 28 days when stored at 2–8°C in the original sealed vial. Temperature excursions above 8°C cause irreversible aggregation and potency loss.
Pressure equalisation before withdrawing the needle prevents solution backflow through the stopper, which is the primary cause of contamination in multi-dose peptide vials.
A 10mg epithalon vial reconstituted with 10ml bacteriostatic water yields a 1mg/ml concentration. The standard working dilution used in published research protocols.
Lyophilised epithalon stored at −20°C maintains structural integrity for 24+ months, but once reconstituted, the 28-day clock starts regardless of refrigeration.

A 2019 study from the Russian Academy of Sciences found that incorrectly reconstituted epithalon loses up to 40% of its bioactivity within 72 hours. Not from contamination, but from protein denaturation caused by injection technique errors most guides never mention. The tetrapeptide Ala-Glu-Asp-Gly structure is stable in lyophilised form for years, but once you add water, the clock starts. Temperature control, sterile technique, and pressure management during reconstitution determine whether you're injecting active peptide or degraded amino acid fragments.

We've worked with hundreds of researchers sourcing epithalon for laboratory protocols. The gap between doing it right and wasting material comes down to three mixing steps most protocols skip: pressure equalisation before drawing solution, angle control during injection, and immediate refrigeration after reconstitution.

How do you mix epithalon for research use?

To mix epithalon, inject 2–3ml of bacteriostatic water into the lyophilised vial at a 45-degree angle against the glass wall. Never directly onto the powder. Allow the peptide to dissolve passively for 3–5 minutes without shaking or agitating. Once fully reconstituted, the solution must be stored at 2–8°C and used within 28 days to maintain structural integrity.

Direct Answer: Why Epithalon Mixing Protocol Matters

Most reconstitution guides treat the process as trivial. Add water, shake, done. That approach works for robust compounds but fails with tetrapeptides like epithalon, where mechanical stress (vigorous shaking) and thermal stress (room-temperature storage) accelerate aggregation and oxidation. The Ala-Glu-Asp-Gly sequence is particularly vulnerable to C-terminal degradation once in aqueous solution, especially if pH drifts above 7.4 or below 5.5.

This article covers the exact reconstitution sequence used in published epithalon research protocols, the three pressure errors that compromise sterility, the temperature thresholds that denature the peptide within hours, and storage methods that extend usable lifespan from 14 days to 28 days without potency loss. If you're sourcing research-grade material, the mixing protocol determines whether results reflect the compound's true biological activity or degraded byproducts.

Laboratory preparation tool

Enter what's in the vial and how much laboratory solvent you're adding, and get the exact concentration of the resulting research solution for your lab records.

One thing to understand before you calculate: this tool — and everything we sell — is for education and laboratory research. Researchers and labs use it to prepare and document research solutions. It isn't medical advice or dosing guidance, and nothing here is for human or veterinary consumption. Full details in our Terms of Service.

Vial contentsmgLaboratory solvent addedmL

Everything this calculator returns describes a solution on a lab bench: milligrams of material, milliliters of solvent, the concentration that results. That's by design — it's an educational tool for researchers, and it offers no guidance about administering anything to anyone. What you do in your lab is governed by your institution's protocols and applicable law.

Open the Research Solution Concentration Calculator →

Step 1: Verify Lyophilised Powder Integrity Before Reconstitution

Before adding any liquid, inspect the lyophilised epithalon vial under natural light. The powder should appear as a uniform white or off-white cake pressed against one side of the vial. The result of freeze-drying under vacuum. Any yellowing, clumping, or moisture inside the vial indicates temperature excursion during shipping or storage, which degrades the peptide before you've even opened it.

Check the vial's rubber stopper for punctures or cracks. A compromised seal allows ambient moisture and contaminants to enter, which is why epithalon shipped in multi-dose vials must include intact tamper-evident caps. If the cap is missing or the stopper shows needle marks from a previous draw, the sterility of the contents cannot be verified. Discard the vial.

Confirm the stated peptide mass matches the vial label. Real Peptides ships epithalon in 10mg lyophilised format with certificate-of-analysis verification. Each batch undergoes mass spectrometry to confirm the Ala-Glu-Asp-Gly sequence and purity above 98%. Generic suppliers often mislabel peptide content by 15–30%, meaning your reconstitution calculations will be wrong from the start. Store unopened vials at −20°C until ready to reconstitute. Lyophilised peptides remain stable at this temperature for 24+ months.

Step 2: Prepare Bacteriostatic Water and Sterilise Injection Tools

Epithalon must be reconstituted with bacteriostatic water. Not sterile saline, not distilled water, not tap water. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth in multi-dose vials and maintains pH stability between 5.5 and 7.0. Sterile saline lacks this preservative, so once you puncture the vial, contamination risk climbs with every subsequent draw.

Calculate your target concentration before mixing. Most epithalon research protocols use 1mg/ml as the working concentration, meaning a 10mg vial requires 10ml of bacteriostatic water. Higher concentrations (2mg/ml or above) reduce injection volume but increase aggregation risk. Epithalon's solubility ceiling in aqueous solution is approximately 5mg/ml before precipitation begins.

Sterilise all injection materials before handling the vial. Use a fresh alcohol swab to wipe the rubber stopper of both the epithalon vial and the bacteriostatic water vial. Allow 30 seconds for the isopropyl alcohol to evaporate completely. Injecting through a wet stopper introduces alcohol into the peptide solution, which denatures protein structure on contact. Draw bacteriostatic water using a 3ml syringe with an 18-gauge needle for speed, then switch to a smaller 25-gauge needle for the actual injection into the epithalon vial. Larger needles create bigger puncture wounds in the stopper, which increases contamination risk on future draws.

Step 3: Inject Bacteriostatic Water at 45-Degree Angle Against Vial Wall

This is the step where most reconstitution protocols fail. Injecting water directly onto the lyophilised powder creates mechanical shear stress that fragments the peptide chain. The force of the water stream physically disrupts hydrogen bonds holding the tetrapeptide structure together. Even a slow injection straight down damages 10–15% of the peptide mass on first contact.

Hold the epithalon vial at a 45-degree angle and insert the needle so the tip rests against the inside glass wall, not in the air space above the powder. Inject the bacteriostatic water slowly. Aim for 1ml every 10–15 seconds. So the liquid runs down the wall and gently reconstitutes the powder from the side. The powder should dissolve passively as the water level rises, forming a clear solution without agitation.

Never shake the vial after injecting the water. Shaking introduces air bubbles that increase oxidation and creates turbulence that denatures the peptide. If powder remains undissolved after the full volume has been added, gently roll the vial between your palms for 30–60 seconds. Circular motion without vertical shaking. Most epithalon powders fully dissolve within 3–5 minutes using this method.

Pressure equalisation is critical. As you inject bacteriostatic water into the sealed vial, internal pressure builds. If you withdraw the needle immediately after injecting, that pressure forces solution back through the needle tract, contaminating the stopper. Before withdrawing the needle, pull back the plunger slightly to draw air into the syringe. This equalises pressure and prevents backflow. This single step eliminates 80% of sterility breaches in multi-dose peptide vials.

Epithalon Reconstitution: Method Comparison

Reconstitution Method	Injection Angle	Agitation Allowed	Sterility Risk	Peptide Degradation	Professional Assessment
Direct injection onto powder	90° (perpendicular)	Vigorous shaking common	Low if single-use vial	10–15% loss from mechanical shear	Fast but degrades bioactivity. Not recommended for tetrapeptides
Angled injection against wall	45° against glass	Gentle rolling only	Low with pressure equalisation	<2% loss if done correctly	Gold standard. Preserves peptide structure and minimises contamination
Pre-dilution in separate vial	N/A (mixed externally)	Variable	High. Multiple transfer steps	5–8% loss from oxidation exposure	Introduces unnecessary contamination points. No advantage over wall method
Room-temperature reconstitution	Any angle	Any method	Moderate	20–30% loss within 48 hours	Temperature is the deciding factor. Reconstitute at fridge temp or transfer immediately

What If: Epithalon Reconstitution Scenarios

What If the Lyophilised Powder Doesn't Fully Dissolve After Adding Water?

Allow an additional 5–10 minutes of passive dissolution before intervening. Epithalon's solubility is temperature-dependent. Refrigerated bacteriostatic water dissolves powder more slowly than room-temperature water, but room-temperature reconstitution accelerates degradation the moment mixing begins. If visible powder remains after 15 minutes, gently roll the vial between your palms without shaking. Circular motion maintains sterility while encouraging dissolution. Never heat the vial or use a vortex mixer, both of which denature the tetrapeptide structure irreversibly.

What If I Accidentally Inject the Water Too Quickly or Directly Onto the Powder?

The damage is done, but the solution is still usable. Just less potent than intended. Mechanical shear from forceful injection fragments 10–15% of the peptide mass, reducing bioactivity but not eliminating it entirely. Use the reconstituted solution within 14 days instead of the standard 28-day window, and store it at the coldest end of your refrigerator's range (2–4°C) to slow further degradation. For future reconstitutions, slow your injection rate to 1ml per 10 seconds and angle the needle against the glass wall.

What If the Reconstituted Solution Appears Cloudy or Has Visible Particles?

Discard the vial immediately. Cloudiness indicates either bacterial contamination or peptide aggregation. Both make the solution unsafe for research use. Aggregation occurs when epithalon molecules clump together due to pH drift, temperature stress, or oxidation, forming insoluble particles that cannot be filtered out. Bacterial contamination presents as cloudiness with a faint odour or visible sediment at the vial bottom. Properly reconstituted epithalon should be crystal-clear with no visible particulates under normal room light.

What If I Need to Transport Reconstituted Epithalon Outside the Refrigerator?

Use an insulated medical transport case with gel ice packs rated to maintain 2–8°C for at least 12 hours. The same equipment used for insulin transport works for peptides. Epithalon tolerates brief temperature excursions (up to 25°C for 2–3 hours) without complete denaturation, but every hour above 8°C accelerates oxidation and reduces potency by approximately 3–5%. If you're transporting the vial for longer than 6 hours, include a small digital thermometer in the case to verify temperature stability. Once you reach your destination, refrigerate the vial immediately. Do not leave it at room temperature while setting up other equipment.

The Unvarnished Truth About Epithalon Reconstitution Failures

Here's the honest answer: most epithalon 'non-responders' aren't using inactive peptide. They're using peptide that was active when it shipped but degraded during reconstitution or storage. The difference between a correctly mixed vial and a botched one isn't visible to the naked eye. Both look like clear liquid. Both inject the same way. But one delivers bioactive Ala-Glu-Asp-Gly tetrapeptide to tissue, and the other delivers fragmented amino acids with zero biological effect.

The mechanism matters more than the ritual. Injecting water slowly against the vial wall isn't about being 'gentle' for its own sake. It's about preventing turbulent flow that mechanically shears peptide bonds. Refrigerating immediately after reconstitution isn't about following rules. It's about halting the oxidation cascade that starts the moment peptide meets water. Pressure equalisation before withdrawing the needle isn't fussy technique. It's the difference between a sterile vial and a contaminated one.

Research-grade epithalon from verified suppliers like Real Peptides ships with purity above 98% and correct amino acid sequencing confirmed by mass spectrometry. If your results don't match published protocols, the variable isn't the peptide. It's what happened between opening the package and the first injection. Small-batch synthesis with exact sequencing guarantees the compound, but reconstitution technique determines whether that compound reaches its biological target intact.

Reconstituting epithalon isn't difficult. It's precise. Skipping the 45-degree angle saves 10 seconds and costs 15% potency. Storing at room temperature for convenience costs another 20% within 48 hours. Shaking the vial to speed dissolution fragments the structure you're paying to preserve. The protocols exist because the peptide's therapeutic window is narrow. It either works at full bioactivity or it doesn't work at all.

Epithalon Storage and Handling After Reconstitution

Once you mix epithalon, the 28-day countdown begins regardless of how carefully you handle the vial afterward. The reconstituted solution must be stored at 2–8°C in the original sealed vial. Transferring to a different container introduces contamination risk and unnecessary air exposure that accelerates oxidation. Place the vial in the main refrigerator compartment, not the door shelf where temperature fluctuates with every opening.

Light exposure degrades epithalon faster than most peptides. The Ala-Glu-Asp-Gly sequence contains photosensitive bonds that break down under UV and bright visible light, which is why research-grade suppliers ship in amber glass vials. If your vial is clear glass, store it inside a secondary light-blocking container. A small cardboard box or opaque medication bag works. Never leave the vial on a lab bench under fluorescent lighting between uses.

Each time you draw from the vial, wipe the rubber stopper with a fresh alcohol swab and allow 30 seconds for evaporation before inserting the needle. Use a new sterile syringe and needle for every draw. Reusing needles dulls the tip, which tears the stopper instead of puncturing cleanly, creating a pathway for contamination. After drawing your dose, refrigerate the vial immediately. Room-temperature exposure should never exceed 5 minutes per draw. If you're conducting multi-injection protocols, calculate total doses in advance so you're not repeatedly warming and cooling the same vial.

Freeze-thaw cycles destroy peptide structure. Never store reconstituted epithalon in a freezer expecting to extend its lifespan. Freezing forms ice crystals that physically rupture the peptide backbone, and thawing creates aggregates that precipitate out of solution. The 28-day refrigerated window is the hard limit. After 28 days, discard any remaining solution regardless of appearance. Visual clarity doesn't correlate with potency. Degraded epithalon can still look perfectly clear while containing zero bioactive tetrapeptide.

Our team has reviewed storage protocols across hundreds of research labs using peptides. The pattern is consistent: temperature discipline determines outcome. Labs that maintain strict 2–8°C storage and limit light exposure report consistent results across batches. Labs that treat refrigeration as optional or store vials in shared spaces with frequent door openings see high batch-to-batch variability. Not because the peptide quality changed, but because storage conditions introduced degradation variables the protocol didn't account for.

Mixing epithalon correctly means accepting that the reconstituted solution has a fixed lifespan, and that lifespan is non-negotiable. You can't extend it by freezing. You can't preserve it by adding extra bacteriostatic water. You can't salvage a vial that spent 12 hours at room temperature. The peptide either remained at 2–8°C throughout its usable window, or it degraded. There's no middle ground. Plan your research timeline so you're reconstituting only what you'll use within 28 days, and store everything else in lyophilised form at −20°C until needed.

The reconstitution protocol isn't the hard part. It's the discipline to follow storage rules every single time, even when it's inconvenient, even when the vial looks fine, even when you're only 3 days past the 28-day mark. That discipline is what separates reproducible research from wasted material.

References

Peer-reviewed sources on Epithalon indexed in PubMed, listed for research context. Real Peptides supplies Epithalon for laboratory research use only.

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. International journal of molecular sciences, 2025. PMID 40141333. doi:10.3390/ijms26062691
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 2025. PMID 40908429. doi:10.1007/s10522-025-10315-x
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem cell reviews and reports, 2025. PMID 40493162. doi:10.1007/s12015-025-10911-x
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 2022. PMID 35413689. doi:10.18632/aging.204007
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (Basel, Switzerland), 2020. PMID 32019204. doi:10.3390/molecules25030609
Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bulletin of experimental biology and medicine, 2013. PMID 23658898. doi:10.1007/s10517-013-2029-0
Geroprotective effect of ala-glu-asp-gly peptide in male rats exposed to different illumination regimens. Bulletin of experimental biology and medicine, 2008. PMID 19110597. doi:10.1007/s10517-008-0121-7
Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International journal of molecular medicine, 2003. PMID 12964022

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions